Anti-obesity drug discovery: advances and challenges.

Anti-obesity drug discovery: advances and challenges.
复制标题

DOI:
10.1038/s41573-021-00337-8
复制
发表时间:
2022-03
期刊:
Nature reviews. Drug discovery
影响因子:
--
通讯作者:
DiMarchi RD
DiMarchi RD
中科院分区:
其他
文献类型:
--
作者:
Müller TD;Blüher M;Tschöp MH;DiMarchi RD

文献摘要

参考文献

被引文献

相似文献

过去半个世纪在高血压、成人糖尿病和胆固醇升高等与体重过重密切相关的疾病的治疗方面取得了巨大进展。然而,肥胖的治疗本身已被证明在很大程度上对治疗产生抵抗力,抗肥胖药物 (AOM) 往往疗效不足且安全性可疑。在这里,我们概述了 AOM 的发展历史,重点关注经验教训和持续存在的障碍。最近的进展,包括对分子肠-脑通讯的了解的加深,正在激发人们对下一代 AOM 的追求,这些 AOM 似乎能够安全地实现大幅且持续的体重减轻。事实证明,开发能够安全地实现大幅且持续的体重减轻的疗法具有巨大的挑战性。在这里,穆勒等人。概述抗肥胖药物的开发历史,重点介绍经验教训、持续挑战和该领域的最新进展。
Enormous progress has been made in the last half-century in the management of diseases closely integrated with excess body weight, such as hypertension, adult-onset diabetes and elevated cholesterol. However, the treatment of obesity itself has proven largely resistant to therapy, with anti-obesity medications (AOMs) often delivering insufficient efficacy and dubious safety. Here, we provide an overview of the history of AOM development, focusing on lessons learned and ongoing obstacles. Recent advances, including increased understanding of the molecular gut–brain communication, are inspiring the pursuit of next-generation AOMs that appear capable of safely achieving sizeable and sustained body weight loss. The development of therapies that are capable of safely achieving sizeable and sustained body weight loss has proved tremendously challenging. Here, Müller et al. provide an overview of the history of anti-obesity drug development, focusing on lessons learned, ongoing challenges and recent advances in the field.
DOI: 10.1038/ijo.2011.158
发表时间: 2012-06
期刊: International journal of obesity (2005)
影响因子: --
作者:
Astrup A;Carraro R;Finer N;Harper A;Kunesova M;Lean ME;Niskanen L;Rasmussen MF;Rissanen A;Rössner S;Savolainen MJ;Van Gaal L;NN8022-1807 Investigators
通讯作者: NN8022-1807 Investigators
具有设计的生长素蛋白O-酰基转移酶抑制剂的小鼠中的葡萄糖和体重控制。
DOI: 10.1126/science.1196154
发表时间: 2010-12-17
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Barnett BP;Hwang Y;Taylor MS;Kirchner H;Pfluger PT;Bernard V;Lin YY;Bowers EM;Mukherjee C;Song WJ;Longo PA;Leahy DJ;Hussain MA;Tschöp MH;Boeke JD;Cole PA
通讯作者: Cole PA
DOI: 10.1111/j.1476-5381.2011.01717.x
发表时间: 2012-05-01
影响因子: 7.3
作者:
Bailey, R. J.;Walker, C. S.;Hay, D. L.
通讯作者: Hay, D. L.
DOI: 10.1016/s2213-8587(18)30051-2
发表时间: 2018-05-01
影响因子: 44.5
作者:
Ahlqvist, Emma;Storm, Petter;Groop, Leif
通讯作者: Groop, Leif
DOI: 10.1038/s41467-020-16298-2
发表时间: 2020-05-14
影响因子: 16.6
作者:
Alexopoulos, Stephanie J.;Chen, Sing-Young;Hoehn, Kyle L.
通讯作者: Hoehn, Kyle L.